Latest Data & Reports

In the first half of 2026, China’s surgical robot market continued to develop across multiple system categories in parallel.

As of June 30, 2026, MedRobot’s analysis of publicly disclosed procurement awards from public hospitals in mainland China

As of June 30, 2026, MedRobot's analysis of publicly disclosed procurement awards from public hospitals across mainland China.

With at least 611 systems sold in 2025, China’s surgical robot market is shifting from concept-driven growth to structured, clinically led expansion across multiple surgical specialties.

In 2025, 52 NMPA approvals were granted to surgical robots developed by Chinese companies, including both new systems and indication expansions. Orthopedics accounted for the largest share, with 23 approvals.

China’s orthopedic surgical robot market reached at least 168 units in 2025, with domestic manufacturers leading the field and the industry entering a phase of rapid commercialization and clear differentiation.